Commercially available: ready to use consumables and optimized method
18F-FET, an L-tyrosine amino acid analog, is a neuro-oncologic PET agent used in the evaluation of patients with primary brain tumors. 18F-FET PET performs much better than 18F-FDG PET for the diagnosis of such primary brain tumors. Furthermore, 18 F-FET PET imaging also improves disease monitoring by early identification of tumor recurrence and progression.
The AllinOne AIO-18 with radio-HPLC (or any higher model) is suitable for FET process.
- High yield >= 35% ndc
- Process suitable for commercialization
- Formulation requires no compounding prior injection
- Plug and play consumables including HPLC eluents
- No laboratory bench work preparation
- Same 18F source as FDG
|Cassette and reagents set up time||< 1 min|
|Synthesis time||50 min|
|Typical production yield||
36 +/- 4 % ndc
|Radiochemical purity||> 98%|